Back to 
UBS Group AG
UBS Group AG
NERVShowing 8 of 16 quarters
Position history for UBS Group AG's holdings in MINERVA NEUROSCIENCES INC
Yes. Ubs holds 42,208 shares of NERV (Minerva Neurosciences), worth $234,254, as of its Q2 2026 13F filing. It reduced the position by 25,362 shares (-37.5%) from Q1 2026. Ubs has held NERV since Q2 2023, across 13 quarterly 13F filings.
Current Value
$234,254
Current Shares
42,208
Total Value Change
+$206,080
Total Shares Change
+31,656
Quarter-by-Quarter History
Other major holders of NERV: FEDERATED HERMES, INC., Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P., Jupiter Topco LLC